SCHEMBL13615643

SCHEMBL13615643

Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)c4cc(N(c5ccc(C)cc5)c5ccc(C)cc5)ccc4c(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.37
ALDH1A1 P00352 5/20 0.37
TDP1 Q9NUW8 4/20 0.37
L3MBTL1 Q9Y468 4/20 0.37
KDM4E B2RXH2 3/20 0.37
CYP2C19 P33261 2/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
APP P05067 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MEN1 O00255 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
RCE1 Q9Y256 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099861 1.00 ACHE (0.37) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL15762783 1.00 ACHE (0.37) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL15762765 0.98 ACHE (0.40) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL13886621 0.98 ACHE (0.40) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL14424679 0.98 ACHE (0.40) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL14099714 0.97 ACHE (0.39) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL15762782 0.97 ACHE (0.39) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL15762786 0.97 ACHE (0.39) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL15762771 0.97 ACHE (0.39) ACHEALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL14099679 0.97 ACHE (0.39) ACHEALDH1A1TDP1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 ACHE 675/4885ALDH1A1 818/4885TDP1 3634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.